{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:01:31Z","timestamp":1762956091917},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00108-019-0574-y","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T11:32:36Z","timestamp":1551871956000},"page":"468-477","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lupusnephritis"],"prefix":"10.1007","volume":"60","author":[{"given":"J.","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Eisenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"574_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O\u2019Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcon GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V (2016) The frequency and outcome of lupus nephritis: Results from an international inception cohort study. Rheumatology (Oxf) 55:252\u2013262","journal-title":"Rheumatology (Oxf.)"},{"key":"574_CR2","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/art.39594","volume":"68","author":"MG Tektonidou","year":"2016","unstructured":"Tektonidou MG, Dasgupta A, Ward MM (2016) Risk of end-stage renal disease in patients with lupus nephritis, 1971\u20132015: A systematic review and Bayesian Meta-analysis. Arthritis Rheumatol 68:1432\u20131441","journal-title":"Arthritis Rheumatol"},{"key":"574_CR3","first-page":"1047","volume":"35","author":"V Torrente-Segarra","year":"2017","unstructured":"Torrente-Segarra V, Salman Monte TC, Rua-Figueroa I, Sanchez-Alonso F, Lopez-Longo FJ, Galindo-Izquierdo M, Calvo-Alen J, Olive-Marques A, Ibanez-Ruan J, Horcada L, Sanchez-Atrio A, Montilla C, Melero Gonzalez RB, Diez-Alvarez E, Martinez-Taboada V, Andreu JL, Fernandez-Berrizbeitia O, Hernandez-Beriain JA, Gantes M, Hernandez-Cruz B, Pecondon-Espanol A, Marras C, Bonilla G, Pego-Reigosa JM (2017) Juvenile- and adult-onset systemic lupus erythematosus: A\u00a0comparative study in a\u00a0large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol 35:1047\u20131055","journal-title":"Clin Exp Rheumatol"},{"key":"574_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N\u00a0Engl J Med 358:929\u2013939","journal-title":"N Engl J Med"},{"key":"574_CR5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","volume":"24","author":"M Lech","year":"2013","unstructured":"Lech M, Anders HJ (2013) The pathogenesis of lupus nephritis. J\u00a0Am Soc Nephrol 24:1357\u20131366","journal-title":"J Am Soc Nephrol"},{"key":"574_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","volume":"64","author":"Y Ghodke-Puranik","year":"2015","unstructured":"Ghodke-Puranik Y, Niewold TB (2015) Immunogenetics of systemic lupus erythematosus: A comprehensive review. J\u00a0Autoimmun 64:125\u2013136","journal-title":"J Autoimmun"},{"key":"574_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.kint.2016.05.017","volume":"90","author":"HJ Anders","year":"2016","unstructured":"Anders HJ, Rovin B (2016) A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. Kidney Int 90:493\u2013501","journal-title":"Kidney Int"},{"key":"574_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","volume":"163","author":"C Cornaby","year":"2015","unstructured":"Cornaby C, Gibbons L, Mayhew V, Sloan CS, Welling A, Poole BD (2015) B cell epitope spreading: Mechanisms and contribution to autoimmune diseases. Immunol Lett 163:56\u201368","journal-title":"Immunol Lett"},{"key":"574_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-018-0436-2","volume":"25","author":"SK Devarapu","year":"2018","unstructured":"Devarapu SK, Anders HJ (2018) Toll-like receptors in lupus nephritis. J\u00a0Biomed Sci 25:35","journal-title":"J Biomed Sci"},{"key":"574_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","volume":"187","author":"E Villanueva","year":"2011","unstructured":"Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, Kaplan MJ (2011) Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J\u00a0Immunol 187:538\u2013552","journal-title":"J Immunol"},{"key":"574_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12:825\u2013835","journal-title":"Clin J Am Soc Nephrol"},{"key":"574_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJMoa1610528","volume":"376","author":"M Steri","year":"2017","unstructured":"Steri M, Orru V, Idda ML, Pitzalis M, Pala M, Zara I, Sidore C, Faa V, Floris M, Deiana M, Asunis I, Porcu E, Mulas A, Piras MG, Lobina M, Lai S, Marongiu M, Serra V, Marongiu M, Sole G, Busonero F, Maschio A, Cusano R, Cuccuru G, Deidda F, Poddie F, Farina G, Dei M, Virdis F, Olla S, Satta MA, Pani M, Delitala A, Cocco E, Frau J, Coghe G, Lorefice L, Fenu G, Ferrigno P, Ban M, Barizzone N, Leone M, Guerini FR, Piga M, Firinu D, Kockum I, Lima Bomfim I, Olsson T, Alfredsson L, Suarez A, Carreira PE, Castillo-Palma MJ, Marcus JH, Congia M, Angius A, Melis M, Gonzalez A, Alarcon Riquelme ME, da Silva BM, Marchini M, Danieli MG, Del Giacco S, Mathieu A, Pani A, Montgomery SB, Rosati G, Hillert J, Sawcer S, D\u2019Alfonso S, Todd JA, Novembre J, Abecasis GR, Whalen MB, Marrosu MG, Meloni A, Sanna S, Gorospe M, Schlessinger D, Fiorillo E, Zoledziewska M, Cucca F (2017) Overexpression of the Cytokine BAFF and autoimmunity risk. N\u00a0Engl J Med 376:1615\u20131626","journal-title":"N Engl J Med"},{"key":"574_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.imbio.2014.07.004","volume":"219","author":"Y Pang","year":"2014","unstructured":"Pang Y, Yang XW, Song Y, Yu F, Zhao MH (2014) Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro. Immunobiology 219:980\u2013989","journal-title":"Immunobiology"},{"key":"574_CR14","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1093\/ndt\/gfl436","volume":"21","author":"M Trendelenburg","year":"2006","unstructured":"Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Fremeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J (2006) High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 21:3115\u20133121","journal-title":"Nephrol Dial Transplant"},{"key":"574_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ekir.2018.04.010","volume":"3","author":"G Shidham","year":"2018","unstructured":"Shidham G, Ayoub I, Birmingham D, Hebert P, Rovin B, Diamond B, Wofsy D, Hebert L (2018) Limited reliability of the spot urine protein\/Creatinine ratio in the longitudinal evaluation of patients with lupus nephritis. Kidney Int Rep 3:1057\u20131063","journal-title":"Kidney Int Rep"},{"key":"574_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13075-015-0600-y","volume":"17","author":"K Kopetschke","year":"2015","unstructured":"Kopetschke K, Klocke J, Griessbach AS, Humrich JY, Biesen R, Dragun D, Burmester GR, Enghard P, Riemekasten G (2015) The cellular signature of urinary immune cells in Lupus nephritis: New insights into potential biomarkers. Arthritis Res Ther 17:94","journal-title":"Arthritis Res Ther"},{"key":"574_CR17","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1177\/0961203318773643","volume":"27","author":"S Qi","year":"2018","unstructured":"Qi S, Chen Q, Xu D, Xie N, Dai Y (2018) Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis. Lupus 27:1582\u20131590","journal-title":"Lupus"},{"key":"574_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/oarrr.s112829","volume":"8","author":"SC Hsieh","year":"2016","unstructured":"Hsieh SC, Tsai CY, Yu CL (2016) Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems. Open Access Rheumatol 8:81\u201391. \n                    https:\/\/doi.org\/10.2147\/oarrr.s112829","journal-title":"Open Access Rheumatol"},{"key":"574_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/14397595.2015.1074649","volume":"26","author":"A Fatemi","year":"2016","unstructured":"Fatemi A, Samadi G, Sayedbonakdar Z, Smiley A (2016) Anti-C1q antibody in patients with lupus nephritic flare: 18-month follow-up and a\u00a0nested case-control study. Mod Rheumatol 26:233\u2013239","journal-title":"Mod Rheumatol"},{"issue":"2","key":"574_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfy220","volume":"34","author":"S Sethi","year":"2018","unstructured":"Sethi S, Fervenza FC (2018) Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant 34(2):193\u2013199. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfy220","journal-title":"Nephrol Dial Transplant"},{"key":"574_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J\u00a0Am Soc Nephrol 15:241\u2013250","journal-title":"J Am Soc Nephrol"},{"key":"574_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D\u2019Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, Noel LH, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB (2018) Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: Clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789\u2013796","journal-title":"Kidney Int"},{"key":"574_CR23","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarcon","year":"2007","unstructured":"Alarcon GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Alen J, Bastian HM, Vila LM, Reveille JD, LUMINA Study Group (2007) Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: Data from LUMINA, a\u00a0multiethnic US cohort (LUMINA L). Ann Rheum Dis 66:1168\u20131172","journal-title":"Ann Rheum Dis"},{"key":"574_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/art.24538","volume":"61","author":"GJ Pons-Estel","year":"2009","unstructured":"Pons-Estel GJ, Alarcon GS, McGwin G Jr., Danila MI, Zhang J, Bastian HM, Reveille JD, Vila LM, Lumina Study Group (2009) Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a\u00a0multiethnic US cohort. Arthritis Rheum 61:830\u2013839","journal-title":"Arthritis Rheum"},{"issue":"11","key":"574_CR25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dorner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT, European League Against Rheumatism, European Renal Association\u2013European Dialysis and Transplant Association (2012) Joint European league against rheumatism and European renal association-European dialysis and transplant association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71(11):1771\u20131782. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2012-201940","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"574_CR26","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/s0272-6386(00)70262-9","volume":"35","author":"SM Korbet","year":"2000","unstructured":"Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, Lupus Nephritis Collaborative Study Group (2000) Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 35(5):904\u2013914. \n                    https:\/\/doi.org\/10.1016\/s0272-6386(00)70262-9","journal-title":"Am J Kidney Dis"},{"key":"574_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/acr.21664","volume":"64","author":"BH Hahn","year":"2012","unstructured":"Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM, American College of Rheumatology (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (hoboken) 64:797\u2013808","journal-title":"Arthritis Care Res (hoboken)"},{"key":"574_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJM198603063141004","volume":"314","author":"HA Austin 3rd","year":"1986","unstructured":"Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N\u00a0Engl J Med 314:614\u2013619","journal-title":"N Engl J Med"},{"key":"574_CR29","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa043731","volume":"353","author":"EM Ginzler","year":"2005","unstructured":"Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N\u00a0Engl J Med 353:2219\u20132228","journal-title":"N Engl J Med"},{"key":"574_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/ard.2008.102533","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Cauli A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R (2010) The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 69:61\u201364","journal-title":"Ann Rheum Dis"},{"key":"574_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2014-206456","volume":"75","author":"CC Mok","year":"2016","unstructured":"Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL (2016) Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: A\u00a0randomised controlled trial and long-term follow-up. Ann Rheum Dis 75:30\u201336","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"574_CR32","first-page":"89","volume":"37","author":"DJ Park","year":"2019","unstructured":"Park DJ, Kang JH, Lee KE, Bae SC, Chung WT, Choe JY, Jung SY, Kim YS, Lee HS, Lee J, Lee YA, Park SH, Park YJ, Suh CH, Yoo DH, Lee SS (2019) Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: A\u00a0nationwide multicentre study. Clin Exp Rheumatol 37(1):89\u201396","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"574_CR33","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/annrheumdis-2014-206897","volume":"75","author":"F Tamirou","year":"2016","unstructured":"Tamirou F, D\u2019Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, Houssiau FA, MAINTAIN Nephritis Trial Group (2016) Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis 75(3):526\u2013531. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-206897","journal-title":"Ann Rheum Dis"},{"key":"574_CR34","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/gfk073","volume":"21","author":"G Moroni","year":"2006","unstructured":"Moroni G, Gallelli B, Quaglini S, Banfi G, Rivolta E, Messa P, Ponticelli C (2006) Withdrawal of therapy in patients with proliferative lupus nephritis: Long-term follow-up. Nephrol Dial Transplant 21:1541\u20131548","journal-title":"Nephrol Dial Transplant"},{"key":"574_CR35","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1681\/ASN.2007121272","volume":"19","author":"H Bao","year":"2008","unstructured":"Bao H, Liu ZH, Xie HL, Hu WX, Zhang HT, Li LS (2008) Successful treatment of class V+IV lupus nephritis with multitarget therapy. J\u00a0Am Soc Nephrol 19:2001\u20132010","journal-title":"J Am Soc Nephrol"},{"key":"574_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2413637","author":"D Chen","year":"2018","unstructured":"Chen D, Lao M, Zhang J, Zhan Y, Li W, Cai X, Zhan Z (2018) Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus Erythematosus: A retrospective Multicenter study. J\u00a0Immunol Res. \n                    https:\/\/doi.org\/10.1155\/2018\/2413637","journal-title":"J Immunol Res"},{"key":"574_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejim.2016.04.005","volume":"32","author":"G Moroni","year":"2016","unstructured":"Moroni G, Ponticelli C (2016) Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med 32:7\u201312","journal-title":"Eur J Intern Med"},{"key":"574_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5152\/eurjrheum.2018.17096","volume":"5","author":"F Alshaiki","year":"2018","unstructured":"Alshaiki F, Obaid E, Almuallim A, Taha R, El-Haddad H, Almoallim H (2018) Outcomes of rituximab therapy in refractory lupus: A meta-analysis. Eur J Rheumatol 5:118\u2013126. \n                    https:\/\/doi.org\/10.5152\/eurjrheum.2018.17096","journal-title":"Eur J Rheumatol"},{"key":"574_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.autrev.2017.01.010","volume":"16","author":"S Sciascia","year":"2017","unstructured":"Sciascia S, Radin M, Yazdany J, Levy RA, Roccatello D, Dall\u2019Era M, Cuadrado MJ (2017) Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. Autoimmun Rev 16:287\u2013293","journal-title":"Autoimmun Rev"},{"issue":"1","key":"574_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2018.08.025","volume":"95","author":"BH Rovin","year":"2019","unstructured":"Rovin BH, Solomons N, Pendergraft WF 3rd, Dooley MA, Tumlin J, Romero-Diaz J, Lysenko L, Navarra SV, Huizinga RB, AURA-LV Study Group (2019) A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney Int 95(1):219\u2013231. \n                    https:\/\/doi.org\/10.1016\/j.kint.2018.08.025","journal-title":"Kidney Int"},{"issue":"1","key":"574_CR41","doi-asserted-by":"publisher","first-page":"e000239","DOI":"10.1136\/lupus-2017-000239","volume":"4","author":"Z Touma","year":"2017","unstructured":"Touma Z, Gladman DD (2017) Current and future therapies for SLE: Obstacles and recommendations for the development of novel treatments. Lupus Sci Med 4(1):e239. \n                    https:\/\/doi.org\/10.1136\/lupus-2017-000239","journal-title":"Lupus Sci Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0574-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0574-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0574-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:24:21Z","timestamp":1583367861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0574-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0574-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"6 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Schreiber, U.\u00a0Eisenberger und K.\u00a0de Groot geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}